Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.38p
   
  • Change Today:
    -1.53p
  • 52 Week High: 11.90
  • 52 Week Low: 5.25
  • Currency: UK Pounds
  • Shares Issued: 6,141m
  • Volume: 3,255
  • Market Cap: £637.17m
  • RiskGrade: 268

Latest ShareCast News

Results of General Meeting

By Sharecast

Date: Monday 29 Dec 2025

AGY ShareCast News

Allergy Therapeutics starts dosing peanut allerg... 27-Mar-2023 ShareCast
Allergy Therapeutics confident in funding as res... 20-Jan-2023 ShareCast
Allergy Therapeutics pauses production at Freema... 04-Oct-2022 ShareCast
Allegy Therapeutics trades 'robustly' in tough y... 15-Jul-2022 ShareCast
Allergy Therapeutics reports positive results fr... 25-Oct-2021 ShareCast

AGY Regulatory News

Results of General Meeting 29-Dec-2025 13:07 RNS
Results of General Meeting 29-Dec-2025 13:07 RNS
Grassmuno® marketing authorisation in Germany 16-Dec-2025 07:00 RNS
Authority for allotment of New Shares 12-Dec-2025 07:00 RNS
Prelim Results and publication of Annual Report 11-Dec-2025 07:00 RNS

AGY Newspaper Links

Allergy drug firm hit by trials setback 12-Jul-2007 The Independent
Need to Know: Global Business Briefing 25-Mar-2006 Times

AGY Tips & Analysis

FTSE Close: BP and Lloyds lead rally 21-Sep-2010 Daily Mail
Tempus:Allergy Therapeutics 22-Sep-2009 Times
Investment Column:Allergy Therapeutics 22-Sep-2009 The Independent
Market report: Wednesday lastest 14-May-2008 Daily Mail
Market Report: Prudential gains after bid specul... 13-Mar-2008 The Independent

AGY News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 10.38p
Change Today -1.53p
% Change -12.82 %
52 Week High 11.90
52 Week Low 5.25
Volume 3,255
Shares Issued 6,141m
Market Cap £637.17m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Price Trend
93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 05-Jan-2026

Time Volume / Share Price
08:01 1,255 @ 11.15p
08:00 2,000 @ 11.90p
08:00 1 @ 11.90p
08:00 1,999 @ 11.90p

AGY Key Personnel

CEO Manuel Llobet

Top of Page